Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 14 October 2025

Sec. Alloimmunity and Transplantation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1712602

This article is part of the Research TopicMethods in Alloimmunity and Transplantation: 2025View all 9 articles

Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

This article is a correction to:

  1. Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

    1. Read original article
John GillJohn Gill1Andrew A. HouseAndrew A. House2Zain ChaglaZain Chagla3Jean TchervenkovJean Tchervenkov4S. Joseph KimS. Joseph Kim5Amanda VinsonAmanda Vinson6Carlos CerveraCarlos Cervera7Paul A. KeownPaul A. Keown1Sonia Lai Wing SunSonia Lai Wing Sun8Christina KhouryChristina Khoury8Christiane Ghakis*Christiane Ghakis8*
  • 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada
  • 2Department of Medicine, Western University, London, ON, Canada
  • 3Department of Medicine, McMaster University, Hamilton, ON, Canada
  • 4Department of Surgery, McGill University, Montreal, QC, Canada
  • 5Department of Medicine, University of Toronto, Toronto, ON, Canada
  • 6Department of Medicine, Dalhousie University, Halifax, NS, Canada
  • 7Department of Medicine, University of Alberta, Edmonton, AB, Canada
  • 8Medical Affairs, Merck Canada Inc, Kirkland, QC, Canada

A Correction on
Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

By Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C and Ghakis C (2025). Front. Immunol. 16:1618748. doi: 10.3389/fimmu.2025.1618748

There was a mistake in Figure 2 as published. The X axis legend was incorrect and should read: “Days from transplant to onset of the 1st episode of myelotoxicity”. The corrected Figure 2 appears below.

Figure 2
Line graph titled “Cumulative Incidence Function” depicting cumulative incidence over days from transplant to onset of the first episode of myelotoxicity. Three lines represent donor types: LD (red), DD (green), and Combined (black). All lines show similar upward trends, with a Gray's test p-value of 0.9992.

Figure 2. Cumulative incidence of myelotoxicity following transplantation.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cytomegalovirus, kidney transplantation, antiviral prophylaxis and treatment, immunosuppression, superinfection, leukopenia, hospitalization, graft failure

Citation: Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C and Ghakis C (2025) Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada. Front. Immunol. 16:1712602. doi: 10.3389/fimmu.2025.1712602

Received: 24 September 2025; Accepted: 30 September 2025;
Published: 14 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Gill, House, Chagla, Tchervenkov, Kim, Vinson, Cervera, Keown, Sun, Khoury and Ghakis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Christiane Ghakis, Q2hyaXN0aWFuZS5HaGFraXNAbXNkLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.